SI2624865T1 - Stabilizirane formulacije, ki vsebujejo protitelesa proti receptorju anti-interlevkina-4 (IL-4R) - Google Patents

Stabilizirane formulacije, ki vsebujejo protitelesa proti receptorju anti-interlevkina-4 (IL-4R)

Info

Publication number
SI2624865T1
SI2624865T1 SI201131568T SI201131568T SI2624865T1 SI 2624865 T1 SI2624865 T1 SI 2624865T1 SI 201131568 T SI201131568 T SI 201131568T SI 201131568 T SI201131568 T SI 201131568T SI 2624865 T1 SI2624865 T1 SI 2624865T1
Authority
SI
Slovenia
Prior art keywords
interleukin
antibodies
receptor
formulations containing
containing anti
Prior art date
Application number
SI201131568T
Other languages
English (en)
Inventor
Daniel B. Dix
Xiaolin Tang
Original Assignee
Regeneron Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharmaceuticals, Inc. filed Critical Regeneron Pharmaceuticals, Inc.
Priority claimed from EP11770625.9A external-priority patent/EP2624865B1/en
Publication of SI2624865T1 publication Critical patent/SI2624865T1/sl

Links

SI201131568T 2010-10-06 2011-10-05 Stabilizirane formulacije, ki vsebujejo protitelesa proti receptorju anti-interlevkina-4 (IL-4R) SI2624865T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39028310P 2010-10-06 2010-10-06
EP11770625.9A EP2624865B1 (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies
PCT/US2011/054856 WO2012047954A1 (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies

Publications (1)

Publication Number Publication Date
SI2624865T1 true SI2624865T1 (sl) 2018-10-30

Family

ID=45995014

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201131568T SI2624865T1 (sl) 2010-10-06 2011-10-05 Stabilizirane formulacije, ki vsebujejo protitelesa proti receptorju anti-interlevkina-4 (IL-4R)

Country Status (13)

Country Link
AR (1) AR083338A1 (sl)
DK (2) DK3354280T3 (sl)
ES (2) ES2820246T3 (sl)
HK (1) HK1258305A1 (sl)
HR (1) HRP20181822T1 (sl)
HU (1) HUE052089T2 (sl)
LT (1) LT2624865T (sl)
PT (1) PT3354280T (sl)
RS (1) RS57850B1 (sl)
SI (1) SI2624865T1 (sl)
TW (7) TWI498121B (sl)
UA (1) UA111731C2 (sl)
UY (1) UY33652A (sl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3470432T (pt) 2012-08-21 2021-12-14 Regeneron Pharma Métodos para tratamento ou prevenção da asma por meio de administração de um antagonista de il-4r
HUE046410T2 (hu) * 2013-06-21 2020-03-30 Sanofi Biotechnology Eljárások orrpolipózis kezelésére IL-4R-antagonista beadásával
AU2014284235B2 (en) * 2013-06-21 2019-11-21 Regeneron Pharmaceuticals, Inc. Methods for treating nasal polyposis by administering an IL-4R antagonist
US10066017B2 (en) 2014-11-14 2018-09-04 Sanofi Biotechnology Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist
EP4344706A3 (en) 2017-10-30 2024-05-22 Sanofi Biotechnology Methods for treating or preventing asthma by administering an il-4r antagonist

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608693B2 (en) * 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
ES2332082B1 (es) * 2008-07-24 2010-10-26 Consejo Superior De Investigaciones Cientificas (Csic) 45% Sistema de alineacion de patrones en un sustrato mediante litografia por estencil.
CN102066649B (zh) * 2008-09-10 2013-05-15 日本爱克兰工业株式会社 交联丙烯酸系纤维和其制造方法
TW201039854A (en) * 2009-03-06 2010-11-16 Genentech Inc Antibody formulation

Also Published As

Publication number Publication date
TWI782325B (zh) 2022-11-01
TW201924718A (zh) 2019-07-01
DK3354280T3 (da) 2020-09-28
HUE052089T2 (hu) 2021-04-28
UA111731C2 (uk) 2016-06-10
DK2624865T3 (en) 2018-10-22
HK1258305A1 (zh) 2019-11-08
TWI568445B (zh) 2017-02-01
TW201542229A (zh) 2015-11-16
TW201716086A (zh) 2017-05-16
TW202102262A (zh) 2021-01-16
RS57850B1 (sr) 2018-12-31
TWI679988B (zh) 2019-12-21
ES2820246T3 (es) 2021-04-20
LT2624865T (lt) 2018-10-25
TW202320851A (zh) 2023-06-01
TW201221141A (en) 2012-06-01
PT3354280T (pt) 2020-09-01
UY33652A (es) 2012-04-30
HRP20181822T1 (hr) 2018-12-28
TWI498121B (zh) 2015-09-01
TW202026011A (zh) 2020-07-16
TWI690329B (zh) 2020-04-11
ES2687813T3 (es) 2018-10-29
AR083338A1 (es) 2013-02-21
TWI718890B (zh) 2021-02-11

Similar Documents

Publication Publication Date Title
IL283424A (en) Stabilized formulations that include antibodies against the interleukin receptor (IL-4R)
HRP20181821T1 (hr) Stabilizirani pripravci koji sadrže anti-interleukin-6 receptorska (il-6r) antitijela
IL265501A (en) Stabilized liquid formulations containing antibody
HRP20170983T1 (hr) Pripravci s visokom koncentracijom antitijela
RS61082B1 (sr) Stabilno antitelo koje sadrži kompozicije
HK1258305A1 (zh) 含有抗白介素-4受體(il-4r)的抗體的穩定製劑
EP2588141A4 (en) ANTIBODY FORMULATIONS